Leiden University Scholarly Publications

Persistent URL of this record https://hdl.handle.net/1887/100965

Beta release

Statistics of Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib (GRID): an international, multicentre, randomised, placebo-controlled, phase 3 trial
Statistics for this year
PeriodVisitsDownloads
202400
Statistics for the last 3 months
PeriodVisitsDownloads
2024-0500
2024-0600
2024-0700